I am a
Home I AM A Search Login

Papers of the Week

Papers: 5 Feb 2022 - 11 Feb 2022

Pharmacology/Drug Development

2022 Feb 09

J Headache Pain



Early onset of efficacy with fremanezumab in patients with episodic and chronic migraine: subanalysis of two phase 2b/3 trials in Japanese and Korean patients.


Takeshima T, Nakai M, Shibasaki Y, Ishida M, Kim B-K, Ning X, Koga N
J Headache Pain. 2022 Feb 09; 23(1):24.
PMID: 35139816.


Early onset of action has become recognized as an important efficacy feature of preventive migraine treatment, which can help overcome adherence issues commonly associated with older medications. Preventive treatments that target the calcitonin gene-related peptide (CGRP) or the CGRP receptor have been previously shown to provide early onset of action.